About Event
What’s On?
With 800+ mRNA drug candidates in development, over 65% still remain in pre-clinical proof-of-concept stages and the field is beelining towards the first clinical approval beyond infectious disease.
The 3rd mRNA-Based Therapeutics Summit Europe returned to Berlin as the European mRNA community’s most comprehensive forum, to provide a clear strategy and roadmap towards clinical success and regulatory approval, delivering the promise of better mRNA medicines to patients faster.
What You Missed:
- Recognising Key Regulatory Considerations for mRNA Applications & Use of mRNA-LNP Technology with the MHRA’s perspective
- Showcasing WHO’s mRNA Vaccine R&D Priorities & Requirements for Low- & Middle- Income Countries
- Delivery of mRNA Therapeutics for Treatment of Respiratory, Chronic Kidney & Cardiovascular Diseases with Ethris, Pantherna Therapeutics, Mercurna and Elastrin Therapeutics
You Missed Out On:
90%
Of the Speaker Faculty NEW for 2024
4
Interactive Panel Discussions
200+
mRNA-Focused Attendees
1
AI RNA Design & Discovery Focus Day
50+
World-Class Speakers
1
CEO & Future Leaders' Fireside Chat
10+
Hours of Dedicated Networking